Selected research
Industry Research
Non-animal Capsule Industry Research Report 2026
Market perspective
The global Non-animal Capsule market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Non-animal Capsule is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Non-animal Capsule is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Non-animal Capsule include Qingdao Capsule, Lonza (Capsugel), Shanxi GS Capsule, Sunil Healthcare, Suheung Capsule, SIRIO, Robinson Pharma, Qualicaps and Procaps Laboratorios, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Non-animal Capsule market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Non-animal Capsule Market by Company
Qingdao Capsule
Lonza (Capsugel)
Shanxi GS Capsule
Sunil Healthcare
Suheung Capsule
SIRIO
Robinson Pharma
Qualicaps
Procaps Laboratorios
Lefan Capsule
Eurocaps
Er-kang
Catalent
Captek
CapsCanada
Best Formulations
Bahrain Pharma
Aenova
ACG Associated Capsules
Non-animal Capsule Segment by Type
HPMC
Starch
Plant Polysaccharides
Others
Non-animal Capsule Segment by Application
Pharmaceutical
Health Supplements
Others
Non-animal Capsule Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-animal Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-animal Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-animal Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Non-animal Capsule manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Non-animal Capsule by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Non-animal Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- HPMC
- Starch
- Plant Polysaccharides
- Others
Applications
- Pharmaceutical
- Health Supplements
- Others
Companies covered
- Qingdao Capsule
- Lonza (Capsugel)
- Shanxi GS Capsule
- Sunil Healthcare
- Suheung Capsule
- SIRIO
- Robinson Pharma
- Qualicaps
- Procaps Laboratorios
- Lefan Capsule
- Eurocaps
- Er-kang
- Catalent
- Captek
- CapsCanada
- Best Formulations
- Bahrain Pharma
- Aenova
- ACG Associated Capsules
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Non-animal Capsule Market Size (2021-2032)
- 2.2.2 Global Non-animal Capsule Sales (2021-2032)
- 2.2.3 Global Non-animal Capsule Market Average Price (2021-2032)
- 2.3 Non-animal Capsule by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 HPMC
- 2.3.3 Starch
- 2.3.4 Plant Polysaccharides
- 2.3.5 Others
- 2.4 Non-animal Capsule by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical
- 2.4.3 Health Supplements
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Non-animal Capsule Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Non-animal Capsule Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Non-animal Capsule Revenue of Manufacturers (2021-2026)
- 3.4 Global Non-animal Capsule Average Price by Manufacturers (2021-2026)
- 3.5 Global Non-animal Capsule Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Non-animal Capsule, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Non-animal Capsule, Product Type & Application
- 3.8 Global Manufacturers of Non-animal Capsule, Established Date
- 3.9 Global Non-animal Capsule Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Qingdao Capsule
- 4.1.1 Qingdao Capsule Company Information
- 4.1.2 Qingdao Capsule Business Overview
- 4.1.3 Qingdao Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Qingdao Capsule Non-animal Capsule Product Portfolio
- 4.1.5 Qingdao Capsule Recent Developments
- 4.2 Lonza (Capsugel)
- 4.2.1 Lonza (Capsugel) Company Information
- 4.2.2 Lonza (Capsugel) Business Overview
- 4.2.3 Lonza (Capsugel) Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lonza (Capsugel) Non-animal Capsule Product Portfolio
- 4.2.5 Lonza (Capsugel) Recent Developments
- 4.3 Shanxi GS Capsule
- 4.3.1 Shanxi GS Capsule Company Information
- 4.3.2 Shanxi GS Capsule Business Overview
- 4.3.3 Shanxi GS Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanxi GS Capsule Non-animal Capsule Product Portfolio
- 4.3.5 Shanxi GS Capsule Recent Developments
- 4.4 Sunil Healthcare
- 4.4.1 Sunil Healthcare Company Information
- 4.4.2 Sunil Healthcare Business Overview
- 4.4.3 Sunil Healthcare Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sunil Healthcare Non-animal Capsule Product Portfolio
- 4.4.5 Sunil Healthcare Recent Developments
- 4.5 Suheung Capsule
- 4.5.1 Suheung Capsule Company Information
- 4.5.2 Suheung Capsule Business Overview
- 4.5.3 Suheung Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Suheung Capsule Non-animal Capsule Product Portfolio
- 4.5.5 Suheung Capsule Recent Developments
- 4.6 SIRIO
- 4.6.1 SIRIO Company Information
- 4.6.2 SIRIO Business Overview
- 4.6.3 SIRIO Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SIRIO Non-animal Capsule Product Portfolio
- 4.6.5 SIRIO Recent Developments
- 4.7 Robinson Pharma
- 4.7.1 Robinson Pharma Company Information
- 4.7.2 Robinson Pharma Business Overview
- 4.7.3 Robinson Pharma Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Robinson Pharma Non-animal Capsule Product Portfolio
- 4.7.5 Robinson Pharma Recent Developments
- 4.8 Qualicaps
- 4.8.1 Qualicaps Company Information
- 4.8.2 Qualicaps Business Overview
- 4.8.3 Qualicaps Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Qualicaps Non-animal Capsule Product Portfolio
- 4.8.5 Qualicaps Recent Developments
- 4.9 Procaps Laboratorios
- 4.9.1 Procaps Laboratorios Company Information
- 4.9.2 Procaps Laboratorios Business Overview
- 4.9.3 Procaps Laboratorios Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Procaps Laboratorios Non-animal Capsule Product Portfolio
- 4.9.5 Procaps Laboratorios Recent Developments
- 4.10 Lefan Capsule
- 4.10.1 Lefan Capsule Company Information
- 4.10.2 Lefan Capsule Business Overview
- 4.10.3 Lefan Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lefan Capsule Non-animal Capsule Product Portfolio
- 4.10.5 Lefan Capsule Recent Developments
- 4.11 Eurocaps
- 4.11.1 Eurocaps Company Information
- 4.11.2 Eurocaps Business Overview
- 4.11.3 Eurocaps Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Eurocaps Non-animal Capsule Product Portfolio
- 4.11.5 Eurocaps Recent Developments
- 4.12 Er-kang
- 4.12.1 Er-kang Company Information
- 4.12.2 Er-kang Business Overview
- 4.12.3 Er-kang Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Er-kang Non-animal Capsule Product Portfolio
- 4.12.5 Er-kang Recent Developments
- 4.13 Catalent
- 4.13.1 Catalent Company Information
- 4.13.2 Catalent Business Overview
- 4.13.3 Catalent Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Catalent Non-animal Capsule Product Portfolio
- 4.13.5 Catalent Recent Developments
- 4.14 Captek
- 4.14.1 Captek Company Information
- 4.14.2 Captek Business Overview
- 4.14.3 Captek Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Captek Non-animal Capsule Product Portfolio
- 4.14.5 Captek Recent Developments
- 4.15 CapsCanada
- 4.15.1 CapsCanada Company Information
- 4.15.2 CapsCanada Business Overview
- 4.15.3 CapsCanada Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 CapsCanada Non-animal Capsule Product Portfolio
- 4.15.5 CapsCanada Recent Developments
- 4.16 Best Formulations
- 4.16.1 Best Formulations Company Information
- 4.16.2 Best Formulations Business Overview
- 4.16.3 Best Formulations Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Best Formulations Non-animal Capsule Product Portfolio
- 4.16.5 Best Formulations Recent Developments
- 4.17 Bahrain Pharma
- 4.17.1 Bahrain Pharma Company Information
- 4.17.2 Bahrain Pharma Business Overview
- 4.17.3 Bahrain Pharma Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Bahrain Pharma Non-animal Capsule Product Portfolio
- 4.17.5 Bahrain Pharma Recent Developments
- 4.18 Aenova
- 4.18.1 Aenova Company Information
- 4.18.2 Aenova Business Overview
- 4.18.3 Aenova Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Aenova Non-animal Capsule Product Portfolio
- 4.18.5 Aenova Recent Developments
- 4.19 ACG Associated Capsules
- 4.19.1 ACG Associated Capsules Company Information
- 4.19.2 ACG Associated Capsules Business Overview
- 4.19.3 ACG Associated Capsules Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 ACG Associated Capsules Non-animal Capsule Product Portfolio
- 4.19.5 ACG Associated Capsules Recent Developments
5 Global Non-animal Capsule Market Scenario by Region
- 5.1 Global Non-animal Capsule Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Non-animal Capsule Sales by Region: 2021-2032
- 5.2.1 Global Non-animal Capsule Sales by Region: 2021-2026
- 5.2.2 Global Non-animal Capsule Sales by Region: 2027-2032
- 5.3 Global Non-animal Capsule Revenue by Region: 2021-2032
- 5.3.1 Global Non-animal Capsule Revenue by Region: 2021-2026
- 5.3.2 Global Non-animal Capsule Revenue by Region: 2027-2032
- 5.4 North America Non-animal Capsule Market Facts & Figures by Country
- 5.4.1 North America Non-animal Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Non-animal Capsule Sales by Country (2021-2032)
- 5.4.3 North America Non-animal Capsule Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Non-animal Capsule Market Facts & Figures by Country
- 5.5.1 Europe Non-animal Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Non-animal Capsule Sales by Country (2021-2032)
- 5.5.3 Europe Non-animal Capsule Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Non-animal Capsule Market Facts & Figures by Country
- 5.6.1 Asia Pacific Non-animal Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Non-animal Capsule Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Non-animal Capsule Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Non-animal Capsule Market Facts & Figures by Country
- 5.7.1 South America Non-animal Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Non-animal Capsule Sales by Country (2021-2032)
- 5.7.3 South America Non-animal Capsule Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Non-animal Capsule Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Non-animal Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Non-animal Capsule Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Non-animal Capsule Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Non-animal Capsule Sales by Type (2021-2032)
- 6.1.1 Global Non-animal Capsule Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Non-animal Capsule Sales Market Share by Type (2021-2032)
- 6.2 Global Non-animal Capsule Revenue by Type (2021-2032)
- 6.2.1 Global Non-animal Capsule Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Non-animal Capsule Revenue Market Share by Type (2021-2032)
- 6.3 Global Non-animal Capsule Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Non-animal Capsule Sales by Application (2021-2032)
- 7.1.1 Global Non-animal Capsule Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Non-animal Capsule Sales Market Share by Application (2021-2032)
- 7.2 Global Non-animal Capsule Revenue by Application (2021-2032)
- 7.2.1 Global Non-animal Capsule Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Non-animal Capsule Revenue Market Share by Application (2021-2032)
- 7.3 Global Non-animal Capsule Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Non-animal Capsule Value Chain Analysis
- 8.1.1 Non-animal Capsule Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Non-animal Capsule Production Mode & Process
- 8.2 Non-animal Capsule Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Non-animal Capsule Distributors
- 8.2.3 Non-animal Capsule Customers
9 Global Non-animal Capsule Analyzing Market Dynamics
- 9.1 Non-animal Capsule Industry Trends
- 9.2 Non-animal Capsule Industry Drivers
- 9.3 Non-animal Capsule Industry Opportunities and Challenges
- 9.4 Non-animal Capsule Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst